Dr. Hirsch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
760 Frederick Ct
Wyckoff, NJ 07481Phone+1 201-848-4884Fax+1 201-848-5117
Education & Training
- Michael Reese Hospital and Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1985
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1978 - 1982
- Harvard Medical SchoolClass of 1978
Certifications & Licensure
- NJ State Medical License 1989 - 2025
- IL State Medical License 1979 - 1990
- TX State Medical License 1983 - 1986
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Needles Start of enrollment: 2010 Oct 01
- Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 Units Start of enrollment: 2011 Mar 01
- Clinical Evaluation of BD NEXT Pen Needle Start of enrollment: 2012 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 49 citationsMicroneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in p...Ronald J. Pettis, Laurence J. Hirsch, Christoph Kapitza, Leszek Nosek, Ulrike Hövelmann
Diabetes Technology & Therapeutics. 2011-03-27 - 170 citationsSkin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations.Michael Gibney, Christina H. Arce, Karen Byron, Laurence J. Hirsch
Current Medical Research and Opinion. 2010-05-15 - 35 citationsPharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion.Elaine McVey, Laurence J. Hirsch, Diane E. Sutter, Christoph Kapitza, Sibylle Dellweg
Journal of Diabetes Science and Technology. 2012-07-01
Press Mentions
- Mayo Clinic Proceedings Publishes New Insulin Injection and Infusion RecommendationsNovember 25th, 2016
- RSSDI Endorses FIT RecommendationsOctober 28th, 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: